Aggressive immunosuppressive therapy for a refractory case of IgA pemphigus.
Sibley Hash
Kendall
K
Division of Immunodermatology, Department of of Dermatology, Johns Hopkins Medical Institutions, Baltimore, MD 21205, USA.
Rencic
Adrienne
A
Hernandez
Maria Ines
MI
Hashimoto
Takashi
T
Nousari
H Carlos
HC
D000368:Aged; D001707:Biopsy, Needle; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000627:therapeutic use*; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D019085:Fluorescent Antibody Technique, Direct; D005500:Follow-Up Studies; D006801:Humans; D007070:Immunoglobulin A / Q000032:analysis / Q000276:immunology*; D007165:Immunosuppression Therapy / Q000379:methods; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D010392:Pemphigus / Q000276:immunology* / Q000473:pathology / Q000628:therapy*; D010956:Plasmapheresis / Q000379:methods*; D012720:Severity of Illness Index; D016896:Treatment Outcome
D007070:Immunoglobulin A; D007166:Immunosuppressive Agents; D003520:Cyclophosphamide